期刊
ONCOGENE
卷 33, 期 26, 页码 3351-3360出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2013.275
关键词
ATM; signalling; cancer
资金
- ERC [281661]
- Cancer Research UK
- Cancer Research UK [15679] Funding Source: researchfish
- European Research Council (ERC) [281661] Funding Source: European Research Council (ERC)
ATM, the protein kinase mutated in the rare human disease ataxia telangiectasia (A-T), has been the focus of intense scrutiny over the past two decades. Initially this was because of the unusual radiosensitive phenotype of cells from A-T patients, and latterly because investigating ATM signalling has yielded valuable insights into the DNA damage response, redox signalling and cancer. With the recent explosion in genomic data, ATM alterations have been revealed both in the germline as a predisposing factor for cancer and as somatic changes in tumours themselves. Here we review these findings, as well as advances in the understanding of ATM signalling mechanisms in cancer and ATM inhibition as a strategy for cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据